Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Growth 2022-2028
The report requires updating with new data and is sent in 48 hours after order is placed.
As the global economy mends, the 2021 growth of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors will have significant change from previous year. According to our (LP Information) latest study, the global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors market, reaching US$ million by the year 2028. As for the Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors players cover Eli Lilly, Janssen Pharmaceuticals, Astellas, and Boehringer Ingelheim, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
As the global economy mends, the 2021 growth of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors will have significant change from previous year. According to our (LP Information) latest study, the global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors market, reaching US$ million by the year 2028. As for the Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors players cover Eli Lilly, Janssen Pharmaceuticals, Astellas, and Boehringer Ingelheim, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
- Invokana (Canagliflozin)
- Jardiance (Empagliflozin)
- Farxiga/Forxiga (Dapagliflozin)
- Suglat (Ipragliflozin)
- Hospital
- Medical Research Institute
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Eli Lilly
- Janssen Pharmaceuticals
- Astellas
- Boehringer Ingelheim
- AstraZeneca
- Bristol Myers Squibb
- Kotobuki Pharmaceutical
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors by Country/Region, 2017, 2022 & 2028
2.2 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Segment by Type
2.2.1 Invokana (Canagliflozin)
2.2.2 Jardiance (Empagliflozin)
2.2.3 Farxiga/Forxiga (Dapagliflozin)
2.2.4 Suglat (Ipragliflozin)
2.3 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type
2.3.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Type (2017-2022)
2.3.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue and Market Share by Type (2017-2022)
2.3.3 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sale Price by Type (2017-2022)
2.4 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Segment by Application
2.4.1 Hospital
2.4.2 Medical Research Institute
2.4.3 Other
2.5 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application
2.5.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sale Market Share by Application (2017-2022)
2.5.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue and Market Share by Application (2017-2022)
2.5.3 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sale Price by Application (2017-2022)
3 GLOBAL SODIUM/GLUCOSE COTRANSPORTER 2 (SGLT 2) INHIBITORS BY COMPANY
3.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Breakdown Data by Company
3.1.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Annual Sales by Company (2020-2022)
3.1.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Company (2020-2022)
3.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Annual Revenue by Company (2020-2022)
3.2.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Company (2020-2022)
3.2.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Company (2020-2022)
3.3 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sale Price by Company
3.4 Key Manufacturers Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Location Distribution
3.4.2 Players Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR SODIUM/GLUCOSE COTRANSPORTER 2 (SGLT 2) INHIBITORS BY GEOGRAPHIC REGION
4.1 World Historic Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size by Geographic Region (2017-2022)
4.1.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Annual Revenue by Geographic Region
4.2 World Historic Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size by Country/Region (2017-2022)
4.2.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Annual Sales by Country/Region (2017-2022)
4.2.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Annual Revenue by Country/Region
4.3 Americas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth
4.4 APAC Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth
4.5 Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth
4.6 Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth
5 AMERICAS
5.1 Americas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Country
5.1.1 Americas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Country (2017-2022)
5.1.2 Americas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Country (2017-2022)
5.2 Americas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type
5.3 Americas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Region
6.1.1 APAC Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Region (2017-2022)
6.1.2 APAC Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Region (2017-2022)
6.2 APAC Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type
6.3 APAC Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors by Country
7.1.1 Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Country (2017-2022)
7.1.2 Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Country (2017-2022)
7.2 Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type
7.3 Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors by Country
8.1.1 Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Country (2017-2022)
8.1.2 Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Country (2017-2022)
8.2 Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type
8.3 Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors
10.3 Manufacturing Process Analysis of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors
10.4 Industry Chain Structure of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Distributors
11.3 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Customer
12 WORLD FORECAST REVIEW FOR SODIUM/GLUCOSE COTRANSPORTER 2 (SGLT 2) INHIBITORS BY GEOGRAPHIC REGION
12.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size Forecast by Region
12.1.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Forecast by Region (2023-2028)
12.1.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Forecast by Type
12.7 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Eli Lilly
13.1.1 Eli Lilly Company Information
13.1.2 Eli Lilly Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Offered
13.1.3 Eli Lilly Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Eli Lilly Main Business Overview
13.1.5 Eli Lilly Latest Developments
13.2 Janssen Pharmaceuticals
13.2.1 Janssen Pharmaceuticals Company Information
13.2.2 Janssen Pharmaceuticals Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Offered
13.2.3 Janssen Pharmaceuticals Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Janssen Pharmaceuticals Main Business Overview
13.2.5 Janssen Pharmaceuticals Latest Developments
13.3 Astellas
13.3.1 Astellas Company Information
13.3.2 Astellas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Offered
13.3.3 Astellas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Astellas Main Business Overview
13.3.5 Astellas Latest Developments
13.4 Boehringer Ingelheim
13.4.1 Boehringer Ingelheim Company Information
13.4.2 Boehringer Ingelheim Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Offered
13.4.3 Boehringer Ingelheim Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Boehringer Ingelheim Main Business Overview
13.4.5 Boehringer Ingelheim Latest Developments
13.5 AstraZeneca
13.5.1 AstraZeneca Company Information
13.5.2 AstraZeneca Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Offered
13.5.3 AstraZeneca Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 AstraZeneca Main Business Overview
13.5.5 AstraZeneca Latest Developments
13.6 Bristol Myers Squibb
13.6.1 Bristol Myers Squibb Company Information
13.6.2 Bristol Myers Squibb Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Offered
13.6.3 Bristol Myers Squibb Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Bristol Myers Squibb Main Business Overview
13.6.5 Bristol Myers Squibb Latest Developments
13.7 Kotobuki Pharmaceutical
13.7.1 Kotobuki Pharmaceutical Company Information
13.7.2 Kotobuki Pharmaceutical Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Offered
13.7.3 Kotobuki Pharmaceutical Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Kotobuki Pharmaceutical Main Business Overview
13.7.5 Kotobuki Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors by Country/Region, 2017, 2022 & 2028
2.2 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Segment by Type
2.2.1 Invokana (Canagliflozin)
2.2.2 Jardiance (Empagliflozin)
2.2.3 Farxiga/Forxiga (Dapagliflozin)
2.2.4 Suglat (Ipragliflozin)
2.3 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type
2.3.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Type (2017-2022)
2.3.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue and Market Share by Type (2017-2022)
2.3.3 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sale Price by Type (2017-2022)
2.4 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Segment by Application
2.4.1 Hospital
2.4.2 Medical Research Institute
2.4.3 Other
2.5 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application
2.5.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sale Market Share by Application (2017-2022)
2.5.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue and Market Share by Application (2017-2022)
2.5.3 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sale Price by Application (2017-2022)
3 GLOBAL SODIUM/GLUCOSE COTRANSPORTER 2 (SGLT 2) INHIBITORS BY COMPANY
3.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Breakdown Data by Company
3.1.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Annual Sales by Company (2020-2022)
3.1.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Company (2020-2022)
3.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Annual Revenue by Company (2020-2022)
3.2.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Company (2020-2022)
3.2.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Company (2020-2022)
3.3 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sale Price by Company
3.4 Key Manufacturers Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Location Distribution
3.4.2 Players Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR SODIUM/GLUCOSE COTRANSPORTER 2 (SGLT 2) INHIBITORS BY GEOGRAPHIC REGION
4.1 World Historic Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size by Geographic Region (2017-2022)
4.1.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Annual Revenue by Geographic Region
4.2 World Historic Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size by Country/Region (2017-2022)
4.2.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Annual Sales by Country/Region (2017-2022)
4.2.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Annual Revenue by Country/Region
4.3 Americas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth
4.4 APAC Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth
4.5 Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth
4.6 Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth
5 AMERICAS
5.1 Americas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Country
5.1.1 Americas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Country (2017-2022)
5.1.2 Americas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Country (2017-2022)
5.2 Americas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type
5.3 Americas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Region
6.1.1 APAC Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Region (2017-2022)
6.1.2 APAC Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Region (2017-2022)
6.2 APAC Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type
6.3 APAC Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors by Country
7.1.1 Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Country (2017-2022)
7.1.2 Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Country (2017-2022)
7.2 Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type
7.3 Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors by Country
8.1.1 Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Country (2017-2022)
8.1.2 Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Country (2017-2022)
8.2 Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type
8.3 Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors
10.3 Manufacturing Process Analysis of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors
10.4 Industry Chain Structure of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Distributors
11.3 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Customer
12 WORLD FORECAST REVIEW FOR SODIUM/GLUCOSE COTRANSPORTER 2 (SGLT 2) INHIBITORS BY GEOGRAPHIC REGION
12.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size Forecast by Region
12.1.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Forecast by Region (2023-2028)
12.1.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Forecast by Type
12.7 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Eli Lilly
13.1.1 Eli Lilly Company Information
13.1.2 Eli Lilly Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Offered
13.1.3 Eli Lilly Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Eli Lilly Main Business Overview
13.1.5 Eli Lilly Latest Developments
13.2 Janssen Pharmaceuticals
13.2.1 Janssen Pharmaceuticals Company Information
13.2.2 Janssen Pharmaceuticals Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Offered
13.2.3 Janssen Pharmaceuticals Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Janssen Pharmaceuticals Main Business Overview
13.2.5 Janssen Pharmaceuticals Latest Developments
13.3 Astellas
13.3.1 Astellas Company Information
13.3.2 Astellas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Offered
13.3.3 Astellas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Astellas Main Business Overview
13.3.5 Astellas Latest Developments
13.4 Boehringer Ingelheim
13.4.1 Boehringer Ingelheim Company Information
13.4.2 Boehringer Ingelheim Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Offered
13.4.3 Boehringer Ingelheim Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Boehringer Ingelheim Main Business Overview
13.4.5 Boehringer Ingelheim Latest Developments
13.5 AstraZeneca
13.5.1 AstraZeneca Company Information
13.5.2 AstraZeneca Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Offered
13.5.3 AstraZeneca Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 AstraZeneca Main Business Overview
13.5.5 AstraZeneca Latest Developments
13.6 Bristol Myers Squibb
13.6.1 Bristol Myers Squibb Company Information
13.6.2 Bristol Myers Squibb Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Offered
13.6.3 Bristol Myers Squibb Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Bristol Myers Squibb Main Business Overview
13.6.5 Bristol Myers Squibb Latest Developments
13.7 Kotobuki Pharmaceutical
13.7.1 Kotobuki Pharmaceutical Company Information
13.7.2 Kotobuki Pharmaceutical Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Offered
13.7.3 Kotobuki Pharmaceutical Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Kotobuki Pharmaceutical Main Business Overview
13.7.5 Kotobuki Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Invokana (Canagliflozin)
Table 4. Major Players of Jardiance (Empagliflozin)
Table 5. Major Players of Farxiga/Forxiga (Dapagliflozin)
Table 6. Major Players of Suglat (Ipragliflozin)
Table 7. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type (2017-2022) & (Kg)
Table 8. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Type (2017-2022)
Table 9. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Type (2017-2022) & ($ million)
Table 10. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Type (2017-2022)
Table 11. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sale Price by Type (2017-2022) & (USD/Kg)
Table 12. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application (2017-2022) & (Kg)
Table 13. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Application (2017-2022)
Table 14. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Application (2017-2022)
Table 15. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Application (2017-2022)
Table 16. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sale Price by Application (2017-2022) & (USD/Kg)
Table 17. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Company (2020-2022) & (Kg)
Table 18. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Company (2020-2022)
Table 19. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Company (2020-2022)
Table 21. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sale Price by Company (2020-2022) & (USD/Kg)
Table 22. Key Manufacturers Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Producing Area Distribution and Sales Area
Table 23. Players Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Products Offered
Table 24. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Geographic Region (2017-2022) & (Kg)
Table 28. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share Geographic Region (2017-2022)
Table 29. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Country/Region (2017-2022) & (Kg)
Table 32. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Country/Region (2017-2022)
Table 33. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Country (2017-2022) & (Kg)
Table 36. Americas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Country (2017-2022)
Table 37. Americas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Country (2017-2022)
Table 39. Americas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type (2017-2022) & (Kg)
Table 40. Americas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Type (2017-2022)
Table 41. Americas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application (2017-2022) & (Kg)
Table 42. Americas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Application (2017-2022)
Table 43. APAC Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Region (2017-2022) & (Kg)
Table 44. APAC Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Region (2017-2022)
Table 45. APAC Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Region (2017-2022)
Table 47. APAC Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type (2017-2022) & (Kg)
Table 48. APAC Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Type (2017-2022)
Table 49. APAC Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application (2017-2022) & (Kg)
Table 50. APAC Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Application (2017-2022)
Table 51. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Country (2017-2022) & (Kg)
Table 52. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Country (2017-2022)
Table 53. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Country (2017-2022)
Table 55. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type (2017-2022) & (Kg)
Table 56. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Type (2017-2022)
Table 57. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application (2017-2022) & (Kg)
Table 58. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Country (2017-2022) & (Kg)
Table 60. Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type (2017-2022) & (Kg)
Table 64. Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application (2017-2022) & (Kg)
Table 66. Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors
Table 68. Key Market Challenges & Risks of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors
Table 69. Key Industry Trends of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors
Table 70. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Distributors List
Table 73. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Customer List
Table 74. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast by Region (2023-2028) & (Kg)
Table 75. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Forecast by Region
Table 76. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast by Country (2023-2028) & (Kg)
Table 79. Americas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast by Region (2023-2028) & (Kg)
Table 81. APAC Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast by Country (2023-2028) & (Kg)
Table 83. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast by Country (2023-2028) & (Kg)
Table 85. Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast by Type (2023-2028) & (Kg)
Table 87. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share Forecast by Type (2023-2028)
Table 88. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast by Application (2023-2028) & (Kg)
Table 91. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share Forecast by Application (2023-2028)
Table 92. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share Forecast by Application (2023-2028)
Table 94. Eli Lilly Basic Information, Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 95. Eli Lilly Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Offered
Table 96. Eli Lilly Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 97. Eli Lilly Main Business
Table 98. Eli Lilly Latest Developments
Table 99. Janssen Pharmaceuticals Basic Information, Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 100. Janssen Pharmaceuticals Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Offered
Table 101. Janssen Pharmaceuticals Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 102. Janssen Pharmaceuticals Main Business
Table 103. Janssen Pharmaceuticals Latest Developments
Table 104. Astellas Basic Information, Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 105. Astellas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Offered
Table 106. Astellas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 107. Astellas Main Business
Table 108. Astellas Latest Developments
Table 109. Boehringer Ingelheim Basic Information, Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 110. Boehringer Ingelheim Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Offered
Table 111. Boehringer Ingelheim Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 112. Boehringer Ingelheim Main Business
Table 113. Boehringer Ingelheim Latest Developments
Table 114. AstraZeneca Basic Information, Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 115. AstraZeneca Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Offered
Table 116. AstraZeneca Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 117. AstraZeneca Main Business
Table 118. AstraZeneca Latest Developments
Table 119. Bristol Myers Squibb Basic Information, Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 120. Bristol Myers Squibb Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Offered
Table 121. Bristol Myers Squibb Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 122. Bristol Myers Squibb Main Business
Table 123. Bristol Myers Squibb Latest Developments
Table 124. Kotobuki Pharmaceutical Basic Information, Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 125. Kotobuki Pharmaceutical Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Offered
Table 126. Kotobuki Pharmaceutical Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 127. Kotobuki Pharmaceutical Main Business
Table 128. Kotobuki Pharmaceutical Latest Developments
Table 1. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Invokana (Canagliflozin)
Table 4. Major Players of Jardiance (Empagliflozin)
Table 5. Major Players of Farxiga/Forxiga (Dapagliflozin)
Table 6. Major Players of Suglat (Ipragliflozin)
Table 7. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type (2017-2022) & (Kg)
Table 8. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Type (2017-2022)
Table 9. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Type (2017-2022) & ($ million)
Table 10. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Type (2017-2022)
Table 11. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sale Price by Type (2017-2022) & (USD/Kg)
Table 12. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application (2017-2022) & (Kg)
Table 13. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Application (2017-2022)
Table 14. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Application (2017-2022)
Table 15. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Application (2017-2022)
Table 16. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sale Price by Application (2017-2022) & (USD/Kg)
Table 17. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Company (2020-2022) & (Kg)
Table 18. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Company (2020-2022)
Table 19. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Company (2020-2022)
Table 21. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sale Price by Company (2020-2022) & (USD/Kg)
Table 22. Key Manufacturers Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Producing Area Distribution and Sales Area
Table 23. Players Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Products Offered
Table 24. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Geographic Region (2017-2022) & (Kg)
Table 28. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share Geographic Region (2017-2022)
Table 29. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Country/Region (2017-2022) & (Kg)
Table 32. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Country/Region (2017-2022)
Table 33. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Country (2017-2022) & (Kg)
Table 36. Americas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Country (2017-2022)
Table 37. Americas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Country (2017-2022)
Table 39. Americas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type (2017-2022) & (Kg)
Table 40. Americas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Type (2017-2022)
Table 41. Americas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application (2017-2022) & (Kg)
Table 42. Americas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Application (2017-2022)
Table 43. APAC Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Region (2017-2022) & (Kg)
Table 44. APAC Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Region (2017-2022)
Table 45. APAC Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Region (2017-2022)
Table 47. APAC Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type (2017-2022) & (Kg)
Table 48. APAC Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Type (2017-2022)
Table 49. APAC Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application (2017-2022) & (Kg)
Table 50. APAC Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Application (2017-2022)
Table 51. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Country (2017-2022) & (Kg)
Table 52. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Country (2017-2022)
Table 53. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Country (2017-2022)
Table 55. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type (2017-2022) & (Kg)
Table 56. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Type (2017-2022)
Table 57. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application (2017-2022) & (Kg)
Table 58. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Country (2017-2022) & (Kg)
Table 60. Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type (2017-2022) & (Kg)
Table 64. Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application (2017-2022) & (Kg)
Table 66. Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors
Table 68. Key Market Challenges & Risks of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors
Table 69. Key Industry Trends of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors
Table 70. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Distributors List
Table 73. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Customer List
Table 74. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast by Region (2023-2028) & (Kg)
Table 75. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Forecast by Region
Table 76. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast by Country (2023-2028) & (Kg)
Table 79. Americas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast by Region (2023-2028) & (Kg)
Table 81. APAC Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast by Country (2023-2028) & (Kg)
Table 83. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast by Country (2023-2028) & (Kg)
Table 85. Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast by Type (2023-2028) & (Kg)
Table 87. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share Forecast by Type (2023-2028)
Table 88. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast by Application (2023-2028) & (Kg)
Table 91. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share Forecast by Application (2023-2028)
Table 92. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share Forecast by Application (2023-2028)
Table 94. Eli Lilly Basic Information, Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 95. Eli Lilly Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Offered
Table 96. Eli Lilly Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 97. Eli Lilly Main Business
Table 98. Eli Lilly Latest Developments
Table 99. Janssen Pharmaceuticals Basic Information, Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 100. Janssen Pharmaceuticals Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Offered
Table 101. Janssen Pharmaceuticals Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 102. Janssen Pharmaceuticals Main Business
Table 103. Janssen Pharmaceuticals Latest Developments
Table 104. Astellas Basic Information, Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 105. Astellas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Offered
Table 106. Astellas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 107. Astellas Main Business
Table 108. Astellas Latest Developments
Table 109. Boehringer Ingelheim Basic Information, Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 110. Boehringer Ingelheim Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Offered
Table 111. Boehringer Ingelheim Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 112. Boehringer Ingelheim Main Business
Table 113. Boehringer Ingelheim Latest Developments
Table 114. AstraZeneca Basic Information, Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 115. AstraZeneca Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Offered
Table 116. AstraZeneca Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 117. AstraZeneca Main Business
Table 118. AstraZeneca Latest Developments
Table 119. Bristol Myers Squibb Basic Information, Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 120. Bristol Myers Squibb Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Offered
Table 121. Bristol Myers Squibb Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 122. Bristol Myers Squibb Main Business
Table 123. Bristol Myers Squibb Latest Developments
Table 124. Kotobuki Pharmaceutical Basic Information, Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 125. Kotobuki Pharmaceutical Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Offered
Table 126. Kotobuki Pharmaceutical Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 127. Kotobuki Pharmaceutical Main Business
Table 128. Kotobuki Pharmaceutical Latest Developments
LIST OF FIGURES
Figure 1. Picture of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors
Figure 2. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate 2017-2028 (Kg)
Figure 7. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Invokana (Canagliflozin)
Figure 10. Product Picture of Jardiance (Empagliflozin)
Figure 11. Product Picture of Farxiga/Forxiga (Dapagliflozin)
Figure 12. Product Picture of Suglat (Ipragliflozin)
Figure 13. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Type in 2021
Figure 14. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Type (2017-2022)
Figure 15. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumed in Hospital
Figure 16. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market: Hospital (2017-2022) & (Kg)
Figure 17. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumed in Medical Research Institute
Figure 18. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market: Medical Research Institute (2017-2022) & (Kg)
Figure 19. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumed in Other
Figure 20. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market: Other (2017-2022) & (Kg)
Figure 21. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Application (2017-2022)
Figure 22. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Application in 2021
Figure 23. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market by Company in 2021 ($ Million)
Figure 24. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Company in 2021
Figure 25. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Geographic Region (2017-2022)
Figure 26. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Geographic Region in 2021
Figure 27. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Region (2017-2022)
Figure 28. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Country/Region in 2021
Figure 29. Americas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales 2017-2022 (Kg)
Figure 30. Americas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue 2017-2022 ($ Millions)
Figure 31. APAC Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales 2017-2022 (Kg)
Figure 32. APAC Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue 2017-2022 ($ Millions)
Figure 33. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales 2017-2022 (Kg)
Figure 34. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue 2017-2022 ($ Millions)
Figure 35. Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales 2017-2022 (Kg)
Figure 36. Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue 2017-2022 ($ Millions)
Figure 37. Americas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Country in 2021
Figure 38. Americas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Country in 2021
Figure 39. United States Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth 2017-2022 ($ Millions)
Figure 40. Canada Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth 2017-2022 ($ Millions)
Figure 41. Mexico Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth 2017-2022 ($ Millions)
Figure 42. Brazil Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth 2017-2022 ($ Millions)
Figure 43. APAC Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Region in 2021
Figure 44. APAC Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Regions in 2021
Figure 45. China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth 2017-2022 ($ Millions)
Figure 46. Japan Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth 2017-2022 ($ Millions)
Figure 47. South Korea Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth 2017-2022 ($ Millions)
Figure 48. Southeast Asia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth 2017-2022 ($ Millions)
Figure 49. India Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth 2017-2022 ($ Millions)
Figure 50. Australia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth 2017-2022 ($ Millions)
Figure 51. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Country in 2021
Figure 52. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Country in 2021
Figure 53. Germany Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth 2017-2022 ($ Millions)
Figure 54. France Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth 2017-2022 ($ Millions)
Figure 55. UK Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth 2017-2022 ($ Millions)
Figure 56. Italy Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth 2017-2022 ($ Millions)
Figure 57. Russia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth 2017-2022 ($ Millions)
Figure 58. Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Country in 2021
Figure 59. Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Country in 2021
Figure 60. Egypt Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth 2017-2022 ($ Millions)
Figure 61. South Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth 2017-2022 ($ Millions)
Figure 62. Israel Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth 2017-2022 ($ Millions)
Figure 63. Turkey Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth 2017-2022 ($ Millions)
Figure 64. GCC Country Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth 2017-2022 ($ Millions)
Figure 65. Manufacturing Cost Structure Analysis of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors in 2021
Figure 66. Manufacturing Process Analysis of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors
Figure 67. Industry Chain Structure of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
Figure 1. Picture of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors
Figure 2. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate 2017-2028 (Kg)
Figure 7. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Invokana (Canagliflozin)
Figure 10. Product Picture of Jardiance (Empagliflozin)
Figure 11. Product Picture of Farxiga/Forxiga (Dapagliflozin)
Figure 12. Product Picture of Suglat (Ipragliflozin)
Figure 13. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Type in 2021
Figure 14. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Type (2017-2022)
Figure 15. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumed in Hospital
Figure 16. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market: Hospital (2017-2022) & (Kg)
Figure 17. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumed in Medical Research Institute
Figure 18. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market: Medical Research Institute (2017-2022) & (Kg)
Figure 19. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumed in Other
Figure 20. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market: Other (2017-2022) & (Kg)
Figure 21. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Application (2017-2022)
Figure 22. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Application in 2021
Figure 23. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market by Company in 2021 ($ Million)
Figure 24. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Company in 2021
Figure 25. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Geographic Region (2017-2022)
Figure 26. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Geographic Region in 2021
Figure 27. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Region (2017-2022)
Figure 28. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Country/Region in 2021
Figure 29. Americas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales 2017-2022 (Kg)
Figure 30. Americas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue 2017-2022 ($ Millions)
Figure 31. APAC Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales 2017-2022 (Kg)
Figure 32. APAC Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue 2017-2022 ($ Millions)
Figure 33. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales 2017-2022 (Kg)
Figure 34. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue 2017-2022 ($ Millions)
Figure 35. Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales 2017-2022 (Kg)
Figure 36. Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue 2017-2022 ($ Millions)
Figure 37. Americas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Country in 2021
Figure 38. Americas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Country in 2021
Figure 39. United States Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth 2017-2022 ($ Millions)
Figure 40. Canada Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth 2017-2022 ($ Millions)
Figure 41. Mexico Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth 2017-2022 ($ Millions)
Figure 42. Brazil Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth 2017-2022 ($ Millions)
Figure 43. APAC Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Region in 2021
Figure 44. APAC Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Regions in 2021
Figure 45. China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth 2017-2022 ($ Millions)
Figure 46. Japan Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth 2017-2022 ($ Millions)
Figure 47. South Korea Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth 2017-2022 ($ Millions)
Figure 48. Southeast Asia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth 2017-2022 ($ Millions)
Figure 49. India Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth 2017-2022 ($ Millions)
Figure 50. Australia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth 2017-2022 ($ Millions)
Figure 51. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Country in 2021
Figure 52. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Country in 2021
Figure 53. Germany Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth 2017-2022 ($ Millions)
Figure 54. France Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth 2017-2022 ($ Millions)
Figure 55. UK Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth 2017-2022 ($ Millions)
Figure 56. Italy Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth 2017-2022 ($ Millions)
Figure 57. Russia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth 2017-2022 ($ Millions)
Figure 58. Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Country in 2021
Figure 59. Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Country in 2021
Figure 60. Egypt Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth 2017-2022 ($ Millions)
Figure 61. South Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth 2017-2022 ($ Millions)
Figure 62. Israel Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth 2017-2022 ($ Millions)
Figure 63. Turkey Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth 2017-2022 ($ Millions)
Figure 64. GCC Country Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth 2017-2022 ($ Millions)
Figure 65. Manufacturing Cost Structure Analysis of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors in 2021
Figure 66. Manufacturing Process Analysis of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors
Figure 67. Industry Chain Structure of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
